Dissolution Technologies · 2014 · 17 citations · 7 references
PharmacyPharmaceutical AnalysisPharmacologyBioavailabilityClinical PharmacologyDissolution TestingBioavailability AnalysisDissolution ApparatusDissolution MediaDrug DispositionFormulation Effects On DissolutionIn Vitro Dissolution TestingDirect Oral Anticoagulant TherapyDissolution Monitoring By SpectroscopySolubility DeterminationSpectroscopic Dissolution Analysis
Rivaroxaban is an oral anticoagulant that is the first available orally active direct Factor Xa inhibitor. In this study, a UV spectrophotometric method was developed for the determination of rivaroxaban content in pharmaceutical formulations and the amount of rivaroxaban released in tablet dissolution studies. The dissolution profile of rivaroxaban was successfully determined with the validated method.
7
Dissolution Testing for Generic Drugs: An FDA Perspective
Om Anand, Lawrence X. Yu, Dale P. Conner et al. · The AAPS Journal · 2011 · 270 citations · Full text
Kesarin Busaranon, Worapot Suntornsuk, Leena Suntornsuk · Journal of Pharmaceutical and Biomedical Analysis · 2005 · 23 citations
Manthena V. S. Varma, Aditya Mohan Kaushal, Sanjay Garg · Journal of Pharmaceutical and Biomedical Analysis · 2004 · 18 citations